| Document |
Document Title |
|
WO/2003/101980A1 |
The invention relates to a group of novel triazine derivatives which are ligands for human adenosine-A3 receptors, as well as to pharmaceutical compositions containing a pharmacologically active amount of at least one of these compounds ...
|
|
WO/2003/095516A1 |
Treatment of off-gas deriving from the pyrolysis reaction of urea to produce melamine, carried out in liquid phase at a high pressure, wherein the melamine content present in the off-gas is separated by washing the off-gas with a cooling...
|
|
WO/2003/094920A1 |
The present invention concerns the microbicidal activity of certain pyrimidine or triazine containing non-nucleoside reverse transcriptase inhibitors. The compounds of the present invention inhibit the systemic infection of a human being...
|
|
WO/2003/091228A2 |
The invention relates to a method for producing a compound of formula (I) or the salts thereof. In formula (I), Q, X*, Y, Z, R, R1, R2 and R3 are defined as in patent claim 1, and in (Ia), (II): (R* = Hal, R** = Hal), (III): (R* = -Q-R, ...
|
|
WO2001097615A9 |
The invention relates to a herbicidal agent containing the following: A) one or more sulfonylureas of general formula (I) wherein R<1> is C2-C4-alkoxy or CO-R, wherein R is equal to OH, C1-C6-alkoxy or NRR, wherein R and R independently ...
|
|
WO/2003/087213A2 |
Heterocyclic tin compounds, useful as flame retardants and/or as smoke suppressants for halogen-containing polymers, e.g., polyvinyl chloride resins having application as wire and cable coatings, are obtained by reacting a trisubstituted...
|
|
WO/2003/087057A1 |
The invention concerns a compound of the formula (I) wherein Ring A is heterocyclyl; m is 0-4 and each R1 is a group such as hydroxy, halo, trifluoromethyl and cyano; R2 is halo and n is 0-2; and each R4 is a group such as hydroxy, halo,...
|
|
WO/2003/084915A1 |
This invention relates to novel compounds according to the general formula : which are thyroid receptor ligands, preferably antagonists, partial antagonists or partial agonists and to methods for using such compounds in the treatment of ...
|
|
WO/2003/084982A2 |
The present invention relates to improved covalent coupling of two or more entities such as biomolecules, polymer compositions, organic/inorganic molecules/materials, and the like, including their combinations, through one or more novel ...
|
|
WO/2003/084927A1 |
Haloalkenes represented by the general formula (I) which are useful as pest controllers: (I) wherein X1 and X2 are each halogeno; Y is hydrogen or halogeno; n is 0 to 5; and Q is (1) a heterocyclic group selected from among thienyl, fury...
|
|
WO/2003/080697A1 |
The invention concerns a polyisocyanate composition having high mean functionality, obtained by polycondensation of diisocyanate or triisocyanate monomers, comprising: (a) 0.5 to 30 wt. % of compounds bearing a single uretidinedione func...
|
|
WO/2003/080584A1 |
Treatment of off-gas deriving from the pyrolysis reaction of urea to produce melamine, carried out in liquid phase at high pressure, wherein the off-gas is mixed with a cooling gaseous fluid, which rapidly cools the gaseous mixture to th...
|
|
WO/2003/078406A1 |
Abstract A compound of the formula wherein A1 and A2 each, independently of one another, represent -S03 or -S03M, where M represents hydrogen, an alkaline or alkaline earth metal, ammonium or alkylammonium, B1 and B2 each, independently ...
|
|
WO/2003/078724A1 |
A process for improving the sun protection factor (SPF) of cellulosic fibre materials and blends thereof, which comprises contacting said materials with at least one compound of the formula (1): (Formule 1); in which M is hydrogen, an al...
|
|
WO/2003/075875A1 |
UV absorber compositions are described, comprising (a) from 1 to 99 % by weight of a hydroxyphenyltriazine compound of formula (I) wherein R1, R2 and R3 are each independently of the others C1-C18alkyl; C2-C10,alkenyl; or phenyl-C,-C4 al...
|
|
WO/2003/074499A1 |
The invention relates to a method for producing the tautomeric form (I) of 2,4,6-trianilino-p-(carbo-2'-ethylhexyl-1'-oxy)-1,3,5-triazi
ne by the crystallisation of a tautomer mixture in the presence of one or more solvents selected from...
|
|
WO/2003/074498A1 |
A compound represented by the formula (I) [wherein A represents the formula CY1Y2OCY3Y4, CY1Y2SOnCY3Y4, CY1Y2NRCY3Y4, CY1=NCY3Y4, or CY1Y2N=CY3 (wherein n is 0, 1, or 2, and Y1, Y2, Y3, and Y4 each independently represents hydrogen, alky...
|
|
WO/2003/070819A1 |
The contents of clear or lightly colored plastic containers or films are protected from ultraviolet radiation by the incorporation of certain UV absorbers of the class of reactable, durable hydroxyphenylbenzotriazoles in the container or...
|
|
WO/2003/070710A1 |
The invention relates to compounds of formula (I) and the salts thereof (I) wherein R1 - R5, X1 - X4, Y1, Y2 and n and m are defined in formula (I) according to claim 1. Said compounds can be used as herbicides and plant growth regulator...
|
|
WO/2003/069047A1 |
A process for improving the sun protection factor (SPF) of cellulosic fibre materials and blends thereof, which comprises contacting said materials with at least one compound of the formula (1) according to claim 1.
|
|
WO/2003/068759A1 |
Compounds of formula (I) wherein: R1-R6.X.Y are as defined in the description and salts and solvates thereof, are CCR-3 antagonists and are thus indicated to be useful in therapy.
|
|
WO/2003/066601A1 |
Pyrimidine derivatives, which are useful as TIE-2 and/or VEGFR-2 inhibitors are described herein. The described invention also includes methods of making such pyrimidine derivatives as well as methods of using the same in the treatment o...
|
|
WO/2003/066605A1 |
The invention relates to a process for preparing melamine, comprising a cooling step from which a mixture H2O containing NH3, CO2 and H2O is released, wherein: − the mixture and a flow of liquid NH3 are fed to an absorption section&sem...
|
|
WO/2003/066099A1 |
An antidementia drug containing a BEC1 potassium channel inhibitor as the active ingredient. It is proved that the BEC1 potassium channel inhibitor has an effect of ameliorating learning disability and is useful as a preventive or a reme...
|
|
WO/2003/063797A2 |
Novel cycloalkyl compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating dela...
|
|
WO/2003/055600A1 |
A catalyst comprising a cyclic acylurea compound having a cyclic acylurea skeleton represented by the general formula (I): (I) [wherein R is hydrogen or a hydroxyl−protecting group&semi G is carbon or nitrogen&semi and n is 1 or 2, wit...
|
|
WO/2003/053943A1 |
The invention relates to a method for producing pure melamine in a high-pressure method. According to said method, in the first stage, the melamine melt is brought into contact with hot NH¿3? and NH¿3? from the second stage and in the ...
|
|
WO/2003/051119A1 |
The invention relates to a method for the control of weeds (i.e. undesired vegetation) at a locus, which method comprises applying thereto a herbicidally effective amount of at least one compound which is a 3,5-dicyanophenoxy derivative ...
|
|
WO/2003/050237A2 |
Triazine linkers can be used as universal small molecule chips for functional proteomics and sensors. These compounds are prepared by making a first building block by adding a first amine by reductive amination of triazine, making a seco...
|
|
WO/2003/045538A1 |
The invention relates to a method for purifying off-gases from a high-pressure melamine-producing installation, with formation of melamine intermediates. According to the inventive method, the off-gases are brought into contact, in a fir...
|
|
WO/2003/045927A1 |
The invention relates to a method for producing melem-free melamine by means of aqueous processing of a melted mass of melamine which is obtained using a high-pressure method. According to the inventive method, the melted mass of melamin...
|
|
WO/2003/046068A1 |
Compounds of the general formula (I) in which R' is H, C1-C12alkyl; C5-C12cycloalkyl; C2-C18alkyl which is interrupted by one or more O; SR4; OR5; or is a group of formula (II) or (III); R2, R21 and R3 independently of one another, are H...
|
|
WO/2003/045923A1 |
Preventives or remedies for Alzheimer’s disease or amyloid protein fibrosis inhibitors containing, as the active ingredient, compounds having the following general formula (I) or pharmacologically acceptable salts thereof&semi and nitr...
|
|
WO/2003/040111A1 |
A carbamate-functional compound having a structure (I), in which each of R1, R2, and R3 is carbamate-functional is water soluble. Coating compositions, especially waterborne coating compositions, include the carbamate-functional compound...
|
|
WO/2003/040096A2 |
Disclosed are compounds of the formula (I), wherein the variables RN, RC, R1, R25, R2, and R3 are as defined herein. These compounds have activity as inhibitors of betasecretase and are therefore useful in treating a variety of discorder...
|
|
WO/2003/037346A1 |
The invention relates to aryl triazines and uses thereof, including to inhibit lysophosphatidic acid acyltransferase $g(b) (LPAAT-$g(b)) activity and/or proliferation of cells such as tumor cells, where R?1¿-R?5¿ are hydrogen or non-yd...
|
|
WO/2003/035734A1 |
Novel compounds of formula (I) are described, wherein E corresponds to the formula (a) or to the formula (b) and the radicals R¿1?, R¿2?, R¿11?, R¿22?, R'¿22?, R¿33?, and R'¿33? are as defined in claim 1. Compounds of formula (I) ...
|
|
WO/2003/035057A1 |
Novel compounds that are inhibitors of one or most post-proline cleaving proteases, e.g. dipeptidyl peptidase IV, according to general formula (1). R?1¿ is H or CN, X?1¿ is O, S, CH¿2?, CHF, CF¿2?, CH(CH¿3?), C(CH¿3?)¿2? or CH(CN)...
|
|
WO/2003/035628A1 |
The invention relates to a method for preparing alkoxycarbonylamino-triazines of the formula (I) by reacting diaminotriazines or triaminotriazines with dimethylcarbonate in the presence of an alcohol and an alkaline or alkaline-earth met...
|
|
WO/2003/032903A2 |
Trisubstituted triazines can be synthesized from cyanuric chloride. These compounds are useful anti-tubulin agents for treating cancer and proliferative diseases.
|
|
WO/2003/031417A1 |
The invention relates to a compound of the general formula: Z¿1?-O-[m(R¿1?PO¿3?),n(R¿2?HPO¿3?]-Z¿2?, in which [m(R¿1?PO¿3?)] represent a copolyphosphate, with m (R¿1?PO¿3?) units and n (R¿2?HPO¿3?) units; R¿3? represents an ...
|
|
WO/2003/029211A1 |
A difluoroalkene derivative which is sufficiently effective in controlling various pests even when used in a small dose and is highly safe for crops, natural enemies to the pests, and animals&semi and an intermediate for the derivative. ...
|
|
WO/2003/024448A2 |
The invention relates to the inhibition of histone deacetylase. The invention provides compounds e.g. (1) and methods for inhibiting deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell p...
|
|
WO/2003/024945A2 |
The invention relates to a simple, cost-effective method for producing polyphosphates of organic bases. According to said method, a mixture of phosphorus pentaoxide and at least one organic nitrogen base is reacted with at least one comp...
|
|
WO/2003/024926A2 |
The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or bl...
|
|
WO/2003/024939A2 |
In various embodiments the present invention comprises 2,4,6-trisubstituted-1,3,5-triazine capping agents comprising one, two, or three leaving groups as substituents with any remaining substituents being essentially inert to reaction wi...
|
|
WO/2003/024441A1 |
A medicinal composition which exasperates apo AI expression as a remedy for circulatory diseases based on the HDL function enhancement. It is an apo AI expression accelerator which contains a compound represented by the formula (I), a pr...
|
|
WO/2003/022823A1 |
The invention relates to a process for obtaining crystalline melamine from a melamine melt, comprising: a) a cooling step, in which the melamine melt is given a pressure between 0.1 MPa and 20 MPa and a temperature below the melting poin...
|
|
WO/2003/016289A1 |
There are described triazine derivatives of formula (1), wherein R¿1? is an unsubstituted or mono- or poly-hydroxy-, C¿1?-C¿18? alkyl-, C¿1?-C¿18? alkoxy-, amino-, C¿1?-C¿5? monoalkylamino- or di-C¿1?-C¿5? alkylamino-substituted...
|
|
WO/2003/011840A1 |
The present invention relates to the production and purification of melamine and, in particular, to the purification of a crude melamine product, while minimizing impurities comprising at least one of melem, melam, melon, or ureidomelami...
|
